EROSIVE PREPYLORIC CHANGES IN PATIENTS WITH END-STAGE RENAL-FAILURE UNDERGOING MAINTENANCE DIALYSIS TREATMENT

被引:8
|
作者
KANG, JY
WEE, A
CHOONG, HL
WU, AYT
机构
[1] NATL UNIV SINGAPORE HOSP,DEPT PATHOL,SINGAPORE,SINGAPORE
[2] SINGAPORE GEN HOSP,DEPT RENAL MED,SINGAPORE,SINGAPORE
关键词
Campylobacter; Gastritis; Gastroscopy; Haemodialysis; Uraemia;
D O I
10.3109/00365529008997602
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We endoscoped 322 of 422 patients with end-stage renal failure undergoing maintenance dialysis treatment to determine the prevalence of erosive prepyloric changes (EPC) in uraemia. EPC grade 1 was found in 79 patients (25% grade 2 in 16 (5% and grade 3 in 43 (13% EPC grades 2 and 3 were commoner among uraemic patients than among non-uraemic patients presenting for gastroduodenoscopy (13 of 198 = 6%; p < 0.001). Patients with EPC grades 2 and 3 were older, had been receiving dialysis longer, and were more likely to be receiving haemodialysis rather than peritoneal dialysis when compared with patients without EPC. Histologic gastritis of the body and antrum was less common among patients with EPC grades 2 and 3 than among patients without EPC. The prevalence of Campylobacter-like organisms was similar in patients with and without EPC. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:746 / 750
页数:5
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF CEFOTETAN IN PATIENTS WITH END-STAGE RENAL-FAILURE ON MAINTENANCE DIALYSIS
    BROWNING, MJ
    HOLT, HA
    WHITE, LO
    CHAPMAN, ST
    BANKS, RA
    REEVES, DS
    YATES, RA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (01) : 103 - 106
  • [2] TREATMENT OF END-STAGE RENAL-FAILURE BY INTEGRATED DIALYSIS AND TRANSPLANTATION
    MATHEW, TH
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1974, 2 (13) : 492 - 496
  • [3] CONTINUOUS PERITONEAL-DIALYSIS IN THE TREATMENT OF END-STAGE RENAL-FAILURE
    DRATWA, M
    VEREERSTRAETEN, P
    TOUSSAINT, C
    [J]. KIDNEY INTERNATIONAL, 1979, 16 (01) : 94 - 95
  • [4] INTERMITTENT PERITONEAL-DIALYSIS IN THE TREATMENT OF END-STAGE RENAL-FAILURE
    WALKER, RG
    ATKINS, RC
    THOMSON, NM
    SCOTT, DF
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1979, 2 (08) : 393 - 397
  • [5] RESULTS OF DIALYSIS IN MYELOMA WITH END-STAGE RENAL-FAILURE
    DUVIC, C
    VIRON, B
    MICHEL, C
    MIGNON, F
    [J]. REVUE DE MEDECINE INTERNE, 1993, 14 (08): : 792 - 798
  • [6] VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH END-STAGE RENAL-FAILURE AND CHRONIC DIALYSIS
    GROSSMANN, R
    THELEMANN, A
    ALBERT, FW
    BERGBAUER, M
    RICKEN, D
    [J]. MEDIZINISCHE KLINIK, 1988, 83 (22) : 735 - 739
  • [7] DIALYSIS OF PLASMA SOLUBLE LIPOFUSCINS IN PATIENTS WITH END-STAGE RENAL-FAILURE
    HEGEDUS, ZL
    FRANK, HA
    STEINMAN, TI
    NAYAK, U
    [J]. ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1991, 99 (04): : 355 - 363
  • [8] TREATMENT OF END-STAGE RENAL-FAILURE IN SWITZERLAND
    SPERTINI, F
    WAUTERS, JP
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 115 (21) : 722 - 727
  • [9] SELECTION OF PATIENTS FOR END-STAGE RENAL-FAILURE TREATMENT - IS IT POSSIBLE
    HERNANDO, L
    [J]. NEFROLOGIA, 1994, 14 : 20 - 23
  • [10] TREATMENT OF HYPERCALCEMIA WITH PAMIDRONATE IN PATIENTS WITH END-STAGE RENAL-FAILURE
    DAVENPORT, A
    GOEL, S
    MACKENZIE, JC
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1993, 27 (04): : 447 - 451